In the relentless pursuit to decode cancer’s intricate biology, scientists have vastly relied on patient-derived xenograft (PDX) models as a...

Malignant pleural effusion (MPE) continues to challenge oncologists worldwide due to its association with poor patient prognosis and debilitating symptoms....

In a groundbreaking study poised to revolutionize the early diagnosis of esophageal squamous cell carcinoma (ESCC), researchers have unveiled a...

In a groundbreaking advancement for cancer treatment, researchers have demonstrated the feasibility of a novel technique known as range-compensated pencil...

In a groundbreaking study poised to reshape our understanding of leukemia cutis (LC), researchers have unveiled a promising therapeutic avenue...

In a groundbreaking advancement for the early detection and management of brain metastases in patients suffering from non-small cell lung...

In the realm of oncology, pancreatic adenocarcinoma (PaC) remains one of the deadliest cancers, characterized by its aggressive nature and...

Lorlatinib, a third-generation Anaplastic Lymphoma Kinase (ALK) tyrosine kinase inhibitor (TKI), has rapidly emerged as a formidable drug in the...

In a groundbreaking exploration into the optimization of radiotherapy techniques for postoperative left-sided breast cancer, a recent study sheds pivotal...

In the complex journey of cancer care, addressing the comprehensive needs of patients extends far beyond medical treatment alone. Recent...